3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
23
Thoracic
3
Gastrointestinal
3
Sarcoma
2
Other hematologic neoplasm
2
Lymphoid
2
Genitourinary
2
Breast
2
Myeloid
1
Head & Neck
1
Dermatologic
1
Conditions
Head and Neck Neoplasms
27
Squamous Cell Carcinoma of Head and Neck
14
Oropharyngeal Neoplasms
6
Carcinoma, Squamous Cell
6
Neoplasms
5
Lung Neoplasms
4
Thyroid Neoplasms
3
Nasopharyngeal Carcinoma
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Liver Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Epstein-Barr Virus Infections
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Vitamin D Deficiency
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Tonsillar Neoplasms
1
Thyroid Diseases
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thymus Neoplasms
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Pneumothorax
1
Interventions
pembrolizumab
30
Nivolumab
10
Cyclophosphamide
9
fludarabine
7
atezolizumab
7
aldesleukin
5
Paclitaxel
5
Magnetic Resonance Spectroscopy
5
Ipilimumab
5
Carboplatin
5
Biopsy
5
cemiplimab
4
Trastuzumab
4
Interleukin-2
4
Docetaxel
4
Cisplatin
4
spartalizumab
3
durvalumab
3
Specimen Handling
3
Polymerase Chain Reaction
3
Gene Expression Profiling
3
Fulvestrant
3
Fluorouracil
3
tisotumab vedotin
2
tislelizumab
2
palbociclib
2
fludarabine phosphate
2
entinostat
2
avelumab
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Blood Specimen Collection
×
Head & Neck
×
Clear all
NCT03958240
2025-09-15
DECIDE
Institut Claudius Regaud
Phase NA
Recruiting
1,100 enrolled